Gujarat Kidney and Super Speciality IPO: Price Band Fixed at ₹108–₹114 Per Share

Gujarat Kidney and Super Speciality IPO are set to open for subscription on December 22 and close on December 24. The anchor investor portion is scheduled to open on December 19. The company is expected to finalise the basis of allotment by December 26, with the shares slated to debut on the stock exchanges on December 30. Nirbhay Capital Services is acting as the sole merchant banker for the IPO.

Gujarat Kidney and Super Speciality IPO Details

The IPO consists entirely of a fresh issue of 2.2 crore equity shares, with no offer-for-sale component. Gujarat Kidney has set the price band at ₹108–₹114 per equity share, each with a face value of ₹2. Retail investors can apply for a minimum of one lot consisting of 128 shares, translating to an investment of ₹14,592 at the upper end of the price band. Applications can thereafter be made in multiples of 128 shares. 

Gujarat Kidney IPO Reservation

The issue allocation comprises 75% for Qualified Institutional Buyers (QIBs), 15% for non-institutional investors (NIIs), and the remaining 10% reserved for retail investors.

For small high-net-worth individuals (HNIs), the minimum application size is 1,792 shares, requiring an investment of ₹2.04 lakh, while big HNIs must bid for at least 8,832 shares, amounting to an investment of ₹10 lakh.

Use of IPO Proceeds

The company plans to utilise ₹77 crore from the IPO proceeds towards the acquisition of Parekhs Hospital in Ahmedabad and ₹10.78 crore for acquiring an additional stake in its subsidiary, Harmony Medicare, based in Bharuch.

Additionally, ₹12.4 crore will be used for part-payment of the purchase consideration for the already acquired Ashwini Medical Centre. The company has also earmarked ₹30 crore for setting up a new hospital in Vadodara, ₹6.8 crore for the procurement of robotic medical equipment, and ₹1.2 crore for repayment of certain borrowings. The balance funds will be deployed for inorganic expansion and general corporate purposes.

Also Read: Upcoming IPO: Renny Strips Filed DRHP with SEBI for ₹300 Crore IPO

About Gujarat Kidney and Super Speciality Limited

Promoted by Pragnesh Yashwant Singh Bharpoda, Gujarat Kidney operates 7 multi-speciality hospitals and 4 pharmacies, with an aggregate bed capacity of 490. On the financial front, Gujarat Kidney reported a profit of ₹5.4 crore on revenue of ₹15 crore for the quarter ended June 2025. For FY25, net profit surged to ₹9.5 crore from ₹1.7 crore in the previous year, while revenue rose sharply to ₹40 crore from ₹4.8 crore.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.